RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

There is a close association between the recovery of liver injury and glycemic control after SGLT2 inhibitor treatment in Japan

Endocrinology
Hepatology
Author
T Kinoshita et al.
Used Parameters : SMM, VFA
Publication Year : 2018
Country : Japan
Journal : Diabetes Therapy
Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors function not only to reduce hyperglycemia but also to ameliorate liver injury and reduce body weight. The aim of this study was to examine in which subjects SGLT2 inhibitors are more effective for glycemic control, liver injury, and obesity in Japanese subjects with type 2 diabetes mellitus. Methods We enrolled a total of 156 subjects with type 2 diabetes who initiated SGLT2 inhibitor treatment after September 1, 2014 in Kawasaki Medical School (Protocol No. 2375). We …
Full text
List
Powered by KBoard